Ajibade Adesina

Ajibade Adesina is a seasoned professional in pharmacovigilance with extensive experience in drug safety and risk management spanning over a decade. Currently serving as Director of Pharmacovigilance Process Excellence & Learning Strategy at Bristol Myers Squibb, Ajibade has previously held multiple leadership roles, including Associate Director at both Bristol Myers Squibb and Celgene, with a focus on global drug safety and training. Notable contributions include leading training and capability development strategies at Roche and coordinating the Innovative Medicines Initiative (IMI) - Eu2P project, which involved collaboration with universities and pharmaceutical companies to enhance pharmacovigilance education. Academic credentials include a Master's degree in Pharmacovigilance from the University of Hertfordshire, alongside executive education from INSEAD and qualifications in learning and development.